awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36617642-7764F881-C08E-421A-B29A-DD958494D162
Q36617642-7764F881-C08E-421A-B29A-DD958494D162
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36617642-7764F881-C08E-421A-B29A-DD958494D162
Cost-effectivenes of paclitaxel plus cisplatin in advanced non-small-cell lung cancer.
P2860
Q36617642-7764F881-C08E-421A-B29A-DD958494D162
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36617642-7764F881-C08E-421A-B29A-DD958494D162
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
313ae771a5b06d44645e08c76b3434f30ef85b19
P2860
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.